Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024
Talphera Inc. (Nasdaq: TLPH), a specialty pharmaceutical company, has announced it will release its second quarter 2024 financial results after market close on Wednesday, August 14, 2024. The company will host a live webcast and conference call at 4:30 p.m. Eastern Standard Time/1:30 p.m. Pacific Standard Time to discuss the results and provide a business update.
Investors can access the webcast through the company's website or join the conference call by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (international) using the conference ID 28132. The webcast will include a slide presentation, and a replay will be available on Talphera's website for 90 days following the event.
Talphera Inc. (Nasdaq: TLPH), un'azienda farmaceutica specializzata, ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre 2024 dopo la chiusura del mercato, mercoledì 14 agosto 2024. L'azienda ospiterà un webcast in diretta e una teleconferenza alle 4:30 p.m. Eastern Standard Time/1:30 p.m. Pacific Standard Time per discutere i risultati e fornire un aggiornamento aziendale.
Gli investitori possono accedere al webcast tramite il sito web dell'azienda o unirsi alla teleconferenza componendo il numero 1-800-836-8184 (Nord America) o 1-646-357-8785 (internazionale) utilizzando l'ID conferenza 28132. Il webcast includerà una presentazione di diapositive e una registrazione sarà disponibile sul sito di Talphera per 90 giorni dopo l'evento.
Talphera Inc. (Nasdaq: TLPH), una compañía farmacéutica especializada, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 después del cierre del mercado el miércoles 14 de agosto de 2024. La empresa llevará a cabo una transmisión web en vivo y una llamada de conferencia a las 4:30 p.m. Hora Estándar del Este/1:30 p.m. Hora Estándar del Pacífico para discutir los resultados y proporcionar una actualización del negocio.
Los inversores pueden acceder a la transmisión web a través del sitio web de la compañía o unirse a la llamada de conferencia marcando 1-800-836-8184 (Norteamérica) o 1-646-357-8785 (internacional) utilizando el ID de conferencia 28132. La transmisión incluirá una presentación de diapositivas, y se podrá escuchar una repetición en el sitio web de Talphera durante 90 días después del evento.
Talphera Inc. (Nasdaq: TLPH)는 전문 제약 회사로, 2024년 2분기 재무 보고서를 2024년 8월 14일 수요일 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 동부 표준시 오후 4시 30분/태평양 표준시 오후 1시 30분에 결과를 논의하고 사업 업데이트를 제공하는 라이브 웹캐스트 및 컨퍼런스 콜을 개최합니다.
투자자는 회사 웹사이트를 통해 웹캐스트에 액세스하거나, 1-800-836-8184 (북미) 또는 1-646-357-8785 (국제)로 전화를 걸어 컨퍼런스 ID 28132를 사용하여 컨퍼런스 콜에 참여할 수 있습니다. 웹캐스트에는 슬라이드 발표가 포함되며, 이벤트 후 90일 동안 Talphera의 웹사이트에서 다시 볼 수 있습니다.
Talphera Inc. (Nasdaq: TLPH), une entreprise pharmaceutique spécialisée, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 après la fermeture du marché le mercredi 14 août 2024. La société organisera un webinaire en direct et une conférence téléphonique à 16h30 heure normale de l'Est/13h30 heure normale du Pacifique pour discuter des résultats et fournir une mise à jour commerciale.
Les investisseurs peuvent accéder au webinaire via le site web de l'entreprise ou rejoindre la conférence téléphonique en composant le 1-800-836-8184 (Amérique du Nord) ou le 1-646-357-8785 (international) en utilisant l'ID de conférence 28132. Le webinaire comprendra une présentation diaporama et une rediffusion sera disponible sur le site de Talphera pendant 90 jours après l'événement.
Talphera Inc. (Nasdaq: TLPH), ein spezialisiertes Pharmaunternehmen, hat angekündigt, dass es seine Finanzergebnisse des zweiten Quartals 2024 nach Börsenschluss am Mittwoch, den 14. August 2024 veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr Eastern Standard Time/13:30 Uhr Pacific Standard Time ein Live-Webcast und eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren und ein Update zum Unternehmen zu geben.
Investoren können über die Unternehmenswebsite auf den Webcast zugreifen oder sich der Telefonkonferenz anschließen, indem sie 1-800-836-8184 (Nordamerika) oder 1-646-357-8785 (international) anrufen und die Konferenz-ID 28132 verwenden. Der Webcast wird eine Präsentation mit Folien enthalten, und eine Aufzeichnung wird auf der Website von Talphera 90 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
Webcast Information
The webcast can be accessed here or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.
Conference Call Information
Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-second-quarter-2024-financial-results-and-corporate-update-call-and-webcast-on-wednesday-august-14-2024-302214600.html
SOURCE Talphera, Inc.
FAQ
When will Talphera (TLPH) release its Q2 2024 financial results?
What time is Talphera's (TLPH) Q2 2024 earnings call scheduled for?
How can investors access Talphera's (TLPH) Q2 2024 earnings webcast?
What are the conference call details for Talphera's (TLPH) Q2 2024 earnings?
